GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (FRA:PDXN) » Definitions » Earnings per Share (Diluted)

Pro-Dex (FRA:PDXN) Earnings per Share (Diluted) : €1.40 (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pro-Dex Earnings per Share (Diluted)?

Pro-Dex's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was €0.68. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €1.40.

Pro-Dex's EPS (Basic) for the three months ended in Sep. 2024 was €0.69. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was €1.42.

Pro-Dex's EPS without NRI for the three months ended in Sep. 2024 was €0.59. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was €1.62.

During the past 12 months, Pro-Dex's average EPS without NRIGrowth Rate was 38.50% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 20.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 5.90% per year.

During the past 13 years, Pro-Dex's highest 3-Year average EPS without NRI Growth Rate was 159.60% per year. The lowest was -64.60% per year. And the median was 15.50% per year.


Pro-Dex Earnings per Share (Diluted) Historical Data

The historical data trend for Pro-Dex's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro-Dex Earnings per Share (Diluted) Chart

Pro-Dex Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.33 1.30 1.15 1.80 0.56

Pro-Dex Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.16 0.13 0.18 0.42 0.68

Competitive Comparison of Pro-Dex's Earnings per Share (Diluted)

For the Medical Instruments & Supplies subindustry, Pro-Dex's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro-Dex's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's PE Ratio distribution charts can be found below:

* The bar in red indicates where Pro-Dex's PE Ratio falls into.



Pro-Dex Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Pro-Dex's Earnings Per Share (Diluted) for the fiscal year that ended in Jun. 2024 is calculated as

Diluted Earnings Per Share (A: Jun. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1.976-0)/3.571
=0.55

Pro-Dex's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2024 is calculated as

Diluted Earnings Per Share (Q: Sep. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(2.222-0)/3.292
=0.67

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Pro-Dex  (FRA:PDXN) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Pro-Dex Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Pro-Dex's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro-Dex Business Description

Traded in Other Exchanges
Address
2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Pro-Dex Headlines

No Headlines